Restful Legs

Active substance: ARSENIC TRIOXIDE, LYCOPODIUM CLAVATUM SPORE, PULSATILLA VULGARIS, TOXICODENDRON PUBESCENS LEAF, SULFUR, ZINC

TABLET, SOLUBLE · ARSENIC TRIOXIDE 12 [hp_X]/1, LYCOPODIUM CLAVATUM SPORE 6 [hp_X]/1, PULSATILLA VULGARIS 6 [hp_X]/1, TOXICODENDRON PUBESCENS LEAF 6 [hp_X]/1, SULFUR 6 [hp_X]/1, ZINC 12 [hp_X]/1

United StatesActive

Marketing holder: Hyland's Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries

Source: openFDA NDC
Countries with the substance registered: 2

Composition

ARSENIC TRIOXIDE · 12 [hp_X]/1
LYCOPODIUM CLAVATUM SPORE · 6 [hp_X]/1
PULSATILLA VULGARIS · 6 [hp_X]/1
TOXICODENDRON PUBESCENS LEAF · 6 [hp_X]/1
SULFUR · 6 [hp_X]/1
ZINC · 12 [hp_X]/1

Products containing arsenic trioxide in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

Country	Products
EU 4	Arsenic trioxide Accord arsenic trioxide EMEA/H/C/005175 Accord Healthcare S.L.U. Arsenic trioxide medac arsenic trioxide EMEA/H/C/005218 medac Gesellschaft für klinische Spezialpräparate mbH Trisenox arsenic trioxide EMEA/H/C/000388 Teva B.V. Arsenic trioxide Mylan arsenic trioxide EMEA/H/C/005235 Mylan Ireland Limited

Registration

Registration number: 54973-3162
Registration status: Active
Dispensing: Over the counter
Route: ORAL

Sources

product · openFDA NDC · 54973-3162 · Verified 2026-10-09 · open in source
registration_status · openFDA NDC · 54973-3162 · Verified 2026-10-09 · open in source
ingredients.0 · openFDA NDC · 54973-3162 · Verified 2026-10-09 · open in source
ingredients.1 · openFDA NDC · 54973-3162 · Verified 2026-10-09 · open in source
ingredients.2 · openFDA NDC · 54973-3162 · Verified 2026-10-09 · open in source
ingredients.3 · openFDA NDC · 54973-3162 · Verified 2026-10-09 · open in source
ingredients.4 · openFDA NDC · 54973-3162 · Verified 2026-10-09 · open in source
ingredients.5 · openFDA NDC · 54973-3162 · Verified 2026-10-09 · open in source